473 filings
Page 6 of 24
UPLOAD
sxk0zlj
3 Jun 21
Letter from SEC
12:00am
8-K
52n7ogrhhhyj144st1
28 May 21
Entry into a Material Definitive Agreement
4:47pm
8-K
zytm5x9bjr
28 May 21
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
anbnvs eitfpwl
12 May 21
ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments
4:30pm
8-K
n53ekeua4 yop
28 Apr 21
ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale
9:41am
DEFA14A
gbi eke2a1geu
8 Apr 21
Additional proxy soliciting materials
12:00am
S-8
w1l87x
26 Mar 21
Registration of securities for employees
4:21pm
8-K
tx1 rqxat3c
25 Mar 21
ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results
4:30pm
8-K
6hua2
2 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
8oyvgwtsgndz96
3 Feb 21
Entry into a Material Definitive Agreement
5:01pm
424B5
362ll0u2td2 c9ol
3 Feb 21
Prospectus supplement for primary offering
5:01pm
8-K
6qg0e e82q
1 Feb 21
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
8:30am
8-K
73o4uac1pmehgophn8
26 Jan 21
Other Events
8:31am
8-K
7qc9 1ga5
19 Jan 21
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook
4:30pm
8-K
68jsorcr q6l
4 Jan 21
Other Events
8:30am